Invention Grant
- Patent Title: Fusion-proteins based on human ferritin and protease-cleavable peptides and their use as chemotherapeutics carriers
-
Application No.: US16761303Application Date: 2018-11-05
-
Publication No.: US11987604B2Publication Date: 2024-05-21
- Inventor: Aldo Braca
- Applicant: THENA BIOTECH S.R.L.
- Applicant Address: IT Latina
- Assignee: THENA BIOTECH S.R.L.
- Current Assignee: THENA BIOTECH S.R.L.
- Current Assignee Address: IT Latina
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Priority: IT 2017000116184 2017.11.06
- International Application: PCT/IB2018/058655 2018.11.05
- International Announcement: WO2019/087155A 2019.05.09
- Date entered country: 2020-05-04
- Main IPC: C07K14/47
- IPC: C07K14/47 ; A61K9/51 ; A61K47/64 ; A61K47/69 ; A61P35/00

Abstract:
A fusion protein, a nanoparticle composed by a plurality of monomers of said fusion protein, and uses thereof. A fusion protein based on the heavy chain of human ferritin is de-scribed, which includes at the N terminus of the protein at least one metalloproteinase cleavage sequence and a modified PAS polypeptide that acts as a masking polymer that in-creases the protein drug stability, as well as a nanoparticle composed of multiple monomers of said fusion protein, a nucleic acid encoding for said fusion protein, and diagnostic and therapeutic applications thereof.
Public/Granted literature
Information query